Oxaliplatin Injection, Solution, Concentrate
Product Images NDC 16729-332

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Oxaliplatin (NDC 16729-332). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oxaliplatin Injection, Usp 100 mg/20 mL (5 mg/ml)-single-dose Vial-carton (Oxaliplatin Inj 100mg 20ml Carton)

This is a pharmaceutical product label for Oxaliplatin Injection USP used for intravenous use only. The product comes in a single-dose vial only, and sterile aqueous solution. The box contains a free disposable syringe for further required dispensation. The lot and expiry details are also given, along with the product's name. There is also a warning regarding overcoding and a blank area on the label.*

FDA Label Image

Oxaliplatin Injection, Usp 100 mg/20 mL (5 mg/ml)-single-dose Vial-label (Oxaliplatin Inj 100mg 20ml Label)

This is a cautionary label found on a medication vial. It warns that the medication contains a toxic agent and should only be used with a prescription. Users should discard any unused portion and refer to the packaging for proper storage instructions. The medication is intended for intravenous use only and must be diluted before use. It is stored in a temperature-controlled environment and must be protected from light. Further dosage and administration instructions are available in the package insert.*

FDA Label Image

Oxaliplatin Injection, Usp 200 mg/40 mL (5 mg/ml)-single-dose Vial-carton (Oxaliplatin Inj 200mg 40ml Carton)

This appears to be a mixture of different types of information, including what seems to be a label for a medication containing "Oxaliplatin" used for intravenous injections, dosing information (200mg/40mL), storage instructions, and warnings. There are also some references to other products or items, such as "bark & varichifee" and a "Lotand BP 2107". The rest of the text is difficult to read or seems to be a mix of words and characters that do not form coherent sentences or phrases.*

FDA Label Image

Oxaliplatin Injection, Usp 200 mg/40 mL (5 mg/ml)-single-dose Vial-label (Oxaliplatin Inj 200mg 40ml Label)

This is a cautionary label of a medication containing Oxaliplatin, a cytotoxic agent. The medication comes in a vial of 200mg and should be discarded if unused. The dosage and administration should be done by a healthcare professional via intravenous use only. It should be stored at room temperature, between 20° to 25°C (68° to 77°F), protecting it from light and should not be frozen. Further instructions can be found in the package insert.*

FDA Label Image

Oxaliplatin Injection, Usp 50 mg/10 mL (5 mg/ml)-single-dose-carton (Oxaliplatin Inj 50mg 10ml Carton)

Not available. The text seems to be a mix of medical and technical information, including drug names, product packaging, and usage instructions. However, it contains many errors and incomplete sentences that make it difficult to understand.*

FDA Label Image

Oxaliplatin Injection, Usp 50 mg/10 mL (5 mg/ml)-single-dose Vial-label (Oxaliplatin Inj 50mg 10ml Label)

This is a medication that comes in a kit for intravenous use only. It contains oxaliplatin USP, 50mg and is a preservative-free aqueous solution with a concentration of 5mg/mL. The medication should not be added to sodium chloride and should only be used with chloride-containing solutions. The packaging has a varnish-free area of 23x18mm. No further information is available.*

FDA Label Image

Figure 1 (Oxaliplatin Inj Figure 1)

This is a chart displaying DFS Probability values for two treatments (FOLFOX4 and LVBEUZ) with corresponding hazard ratio and stratified logrank test result. The chart also shows the number of events and number of patients at risk for each treatment at different months.*

FDA Label Image

Figure 2 (Oxaliplatin Inj Figure 2)

FDA Label Image

Figure 3 (Oxaliplatin Inj Figure 3)

This is a survival analysis chart for different chemotherapy treatments. It shows the percentage of patients surviving over the course of months for each treatment option. The chart also displays the median survival rate in months for each treatment. The log rank test was used to compare the effectiveness of Eloxatin plus 5-FU/LV and irinotecan plus 5-FU/LV.*

FDA Label Image

Chemical Structure (Oxaliplatin Inj Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.